Trial Profile

Immunogenicity, Safety and Reactogenicity of GSK Biologicals' Influenza GSK2340272A and Fluarix 2009-2010 Vaccines When Co-administered in Elderly Subjects Aged 61 Years and Older.

Status: Completed

Phase of Trial: Phase II

Latest Information Update: 12 Jul 2023

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Influenza A virus vaccine-H1N1 (Primary) ; Influenza virus vaccine
Indications Influenza A virus H1N1 subtype; Influenza virus infections
Focus Pharmacodynamics
Sponsors GlaxoSmithKline; GSK

Most Recent Events

21 Nov 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
09 Nov 2009 Results have been reported by GlaxoSmithKline in a media release.
06 Oct 2009 Status changed from not yet recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com